Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
425.73
-6.27 (-1.45%)
At close: Nov 6, 2026, 4:00 PM EST
425.86
+0.13 (0.03%)
After-hours: Nov 6, 2026, 4:28 PM EST

Elevance Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
5,1395,6625,9805,9875,8946,158
Depreciation & Amortization
6867436591,0601,076817
Other Amortization
803803734685599485
Gain (Loss) on Sale of Assets
---201---
Stock-Based Compensation
240276191289264255
Change in Accounts Receivable
-1,971-2,526-683-1,762-2,510-2,138
Change in Accounts Payable
3,105-720-2721,640824719
Change in Unearned Revenue
-194-15-113290-42-113
Change in Income Taxes
631-297404-103-338140
Change in Insurance Reserves / Liabilities
1,459228-1,8401472,4112,523
Change in Other Net Operating Assets
-77053785-74778-8
Other Operating Activities
-385373629642915
Operating Cash Flow
7,5964,2905,8088,0618,3998,364
Operating Cash Flow Growth
54.64%-26.14%-27.95%-4.02%0.42%-21.74%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,082-1,116-1,256-1,296-1,152-1,087
Cash Acquisitions
3588-4,809-1,552-649-3,476
Investment in Securities
-1,82269586-2,700-2,338-4,056
Other Investing Activities
-137-385-51-24-421-1,019
Investing Cash Flow
-3,006-1,344-5,167-5,572-4,560-9,638

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,2032753392,6002,331
Long-Term Debt Issued
-2,9917,7102,5743,0713,462
Total Debt Issued
2,8556,1947,9852,9135,6715,793
Total Debt Repaid
-2,267-3,867-2,498-2,251-3,574-2,494
Net Debt Issued (Repaid)
5882,3275,4876622,0973,299
Issuance of Common Stock
14679221152182203
Repurchases of Common Stock
-2,196-2,637-3,009-2,775-2,409-2,002
Common Dividends Paid
-1,499-1,529-1,508-1,395-1,229-1,104
Other Financing Activities
2622274127
Financing Cash Flow
-2,935-1,7381,193-3,349-1,318423

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-20-5-6-1-14-10
Miscellaneous Cash Flow Adjustments
---66---
Net Cash Flow
1,6351,2031,762-8612,507-861

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6,5143,1744,5526,7657,2477,277
Free Cash Flow Growth
72.92%-30.27%-32.71%-6.65%-0.41%-24.72%
Free Cash Flow Margin
3.23%1.59%2.57%3.95%4.63%5.25%
Free Cash Flow Per Share
29.7014.1319.5528.5029.8529.48
Levered Free Cash Flow
7,9873,4007,2623,0058,4253,614
Unlevered Free Cash Flow
8,8914,2778,0023,6498,9604,115

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,4101,4101,2391,032878822
Cash Income Tax Paid
315315--1,5941,299
Change in Working Capital
2,260-3,277-1,719-5354231,123
SEC Filings: 10-K · 10-Q